Submitted by roany98@gmail.com on Mon, 07/31/2023 - 12:19
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma (Faculty Presentations)
Martin Hutchings, MD, PhD
Senior Consultant
Department of Haematology and Phase 1 Unit
Rigshospitalet, Copenhagen University Hospital
Professor of Clinical Lymphoma Research
Department of Clinical Medicine, University of Copenhagen
Copenhagen, Denmark
Senior Consultant
Department of Haematology and Phase 1 Unit
Rigshospitalet, Copenhagen University Hospital
Professor of Clinical Lymphoma Research
Department of Clinical Medicine, University of Copenhagen
Copenhagen, Denmark
Loretta J Nastoupil, MD
Associate Professor
Section Chief, Indolent Lymphoma
Department of Lymphoma/Myeloma
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Associate Professor
Section Chief, Indolent Lymphoma
Department of Lymphoma/Myeloma
The University of Texas
MD Anderson Cancer Center
Houston, Texas